Canada’s early contributions and long-standing academic expertise in artificial intelligence are now generating growing funding for and revenue in AI in drug development, but the country’s AI-enabled drug development industry faces significant challenges in coming years, Dr. Ulrik Kristensen, PhD, founder and principal analyst at UK-based Emersion Insights, says in an op-ed.
Topic: Pan-Canadian Artificial Intelligence Strategy
The federal and Quebec governments are teaming up on a $15-million investment to advance responsible development of artificial intelligence, including a new international centre of AI expertise in Montréal.
The Quebec Institute of Artificial Intelligence (Mila) officially opened its new premises in a converted textile factory in Montreal, alongside other key players in the local AI ecosystem.
The governments of Ontario and Quebec have signed a memorandum of understanding to further cooperation in the field of artificial intelligence (AI) with an emphasis on support for 5G technologies. The MOU builds on two existing bi-lateral initiatives — the Evolution of Networked Services through a Corridor in Québec and Ontario for Research and Innovation…
The Univ of Alberta is will become home to the first international research base for DeepMind outside of the UK…
Budget 2017 promises $125 million to launch what it calls a Pan-Canadian Artificial Intelligence Strategy by promoting collaboration between centres of excellence in Montreal, Toronto-Waterloo and Edmonton. This, it says, will “position Canada as a world-leading destination for companies seeking to invest in artificial intelligence and innovation.” What’s missing as Canada seeks to position itself for the future, and this is critically important, is any institutional capacity to prepare Canadians more broadly for the future.